![](/img/cover-not-exists.png)
A phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of etelcalcetide (ONO-5163/AMG 416), a novel intravenous calcimimetic, for secondary hyperparathyroidism in Japanese haemodialysis patients
Fukagawa, Masafumi, Yokoyama, Keitaro, Shigematsu, Takashi, Akiba, Takashi, Fujii, Akifumi, Kuramoto, Takuto, Odani, Motoi, Akizawa, TadaoLanguage:
english
Journal:
Nephrology Dialysis Transplantation
DOI:
10.1093/ndt/gfw408
Date:
January, 2017
File:
PDF, 1.01 MB
english, 2017